Condition: Hypercholesterolemia · Sponsor: Regeneron Pharmaceuticals
This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of hypercholesterolemia (high blood cholesterol levels). The aim of the study is to see how safe and effective alirocumab is when given weekly to adult participants who have hypercholesterolemia. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug once a week * How much study drug is in the blood at different times
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group | Anniston, Alabama, United States | Recruiting |
| Cullman Clinical Trials | Cullman, Alabama, United States | Recruiting |
| Anaheim Clinical Trials | Anaheim, California, United States | Recruiting |
| Cenexel CNS | Los Alamitos, California, United States | Recruiting |
| Diablo Clinical Research - Flourish Research | Walnut Creek, California, United States | Recruiting |
| Tampa Bay Medical Research | Clearwater, Florida, United States | Recruiting |
| Southwest General Healthcare Center | Fort Myers, Florida, United States | Recruiting |
| Precision Clinical Research | Sunrise, Florida, United States | Recruiting |
| K2 Medical Research The Villages | The Villages, Florida, United States | Recruiting |
| Center for Advanced Research and Education | Gainesville, Georgia, United States | Recruiting |
| Balanced Life Health Care Solutions | Lawrenceville, Georgia, United States | Recruiting |
| East-West Medical Research Institute | Honolulu, Hawaii, United States | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07477704